Vivos Therapeutics, Inc. Common Stock
VVOSVivos Therapeutics, Inc. (VVOS) is a healthcare company focused on the diagnosis and treatment of sleep and airway-related disorders. It specializes in non-invasive, outpatient treatments for conditions such as sleep apnea through its proprietary Vivos System, which combines custom oral appliances with advanced digital technology. The company aims to provide minimally invasive solutions to improve patient outcomes related to sleep health and airway function.
Company News
The global sleep apnea devices market is projected to grow from USD 9.5 billion in 2024 to USD 15.8 billion by 2032, with a CAGR of approximately 6%. Growth is driven by rising OSA prevalence, technological advancements, increased awareness, and expanding healthcare infrastructure. North America leads the market with over 45% share, while Asia-Pa...
Vivos Therapeutics (NASDAQ: VVOS) announced the closing of a warrant exercise that generated approximately $4.64 million in gross proceeds. The company exercised 1,982,356 outstanding warrants at a reduced price of $2.34 per share and issued new unregistered warrants to purchase 3,964,712 shares at $2.09 per share. Net proceeds will be used for w...
Vivos Therapeutics, a medical device company specializing in sleep-related breathing disorders, will participate in a fireside chat to discuss its strategic business model, market opportunities, and growth strategies.
Vivos Therapeutics reported Q2 2025 results with declining revenue of $3.8 million, a strategic shift towards medical provider alliances, and increased operating expenses following the Sleep Center of Nevada acquisition.
8 Out of 10 Newly Diagnosed OSA Patients Choose Oral Appliance Therapy Over CPAP and Preferred Vivos’ Flagship CARE Oral Medical Devices 5 to 1 Over Traditional Oral Appliances 8 Out of 10 Newly Diagnosed OSA Patients Choose Oral Appliance Therapy Over CPAP and Preferred Vivos’ Flagship CARE Oral Medical Devices 5 to 1 Over Traditional Oral A...
